ESIH:XETRA:XETRA-iShares MSCI Europe Health Care Sector UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 7.167

Change

+0.02 (+0.24)%

Market Cap

USD 0.60B

Volume

0.15M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.52 (+0.97%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.22 (+1.27%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.50%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.33 (+1.14%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.39 (+1.52%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.33%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

+1.02 (+0.72%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.22 (+0.42%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.19 (+1.11%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.92 (+1.13%)

USD 80.38B

ETFs Containing ESIH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.67% 90% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.67% 90% A- 85% B
Trailing 12 Months  
Capital Gain 10.31% 43% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.31% 42% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.26% 46% F 47% F
Dividend Return 5.26% 45% F 45% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.63% 80% B- 84% B
Risk Adjusted Return 79.29% 69% C- 73% C
Market Capitalization 0.60B 68% D+ 60% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.